SCHEMBL7376245

SCHEMBL7376245

COc1ccc(NC(F)(F)Cc2ccc(Cl)cc2CO)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.39
ALDH1A1 P00352 6/20 0.39
MEN1 O00255 5/20 0.39
GAA P10253 4/20 0.39
L3MBTL1 Q9Y468 3/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KCNH2 Q12809 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
MAPT P10636 4/20 0.37
HTT P42858 2/20 0.37
THRB P10828 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6926419 0.73 MEN1 (0.48) KMT2AALDH1A1MEN1GAAL3MBTL1
SCHEMBL7381283 0.71 MAPT (0.41) KMT2AALDH1A1MEN1GAAL3MBTL1
SCHEMBL14686282 0.69 CA1 (0.47) KMT2AALDH1A1MEN1KDM4EPSEN1
SCHEMBL6920228 0.69 ALDH1A1 (0.49) KMT2AALDH1A1MEN1GAAL3MBTL1
SCHEMBL29493203 0.65 IDO1 (0.50) KMT2AALDH1A1MEN1HPGDTDP1
SCHEMBL1154758 0.65 IDO1 (0.50) KMT2AALDH1A1MEN1HPGDTDP1
SCHEMBL29043085 0.65 MAPT (0.44) KMT2AALDH1A1MEN1KDM4EHPGD
SCHEMBL6926332 0.65 KMT2A (0.42) KMT2AALDH1A1MEN1GAAL3MBTL1
SCHEMBL7379989 0.64 MAPT (0.42) KMT2AALDH1A1MEN1GAAL3MBTL1
SCHEMBL2061056 0.64 KDM4E (0.50) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002050056-A1 BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS MERCK & CO., INC. (US) 2002-06-27 WO disclosed